The results of this study showed that thymosin alpha 1 could decrease proinflammatory cytokines and reduce pancreas injury and had a protective effect in rats with severe acute pancreatitis (SAP). This provides a new strategy for the clinical treatment of SAP.

In patients with severe acute pancreatitis, intensive insulin therapy was superior to conventional insulin therapy in controlling blood glucose and it improved the final outcomes.